- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04046458
De-escalating Vital Sign Checks
Using Predictive Analytics to Reduce Vital Sign Checks in Stable Hospitalized Patients
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Patients in the hospital often report poor sleep. A lack of sleep not only affects a patient's recovery from illness and their overall feeling of wellness, but it is a leading factor in the development of delirium in the hospital. One method for improving sleep in the hospital is to reduce the number of patient care related interruptions that a patient experiences. Vital sign checks at night are one example. In hospitalized patients who are clinically stable, vital sign checks that interrupt sleep are often unnecessary. However, identifying which patients can forego these checks is not a simple task. Currently, the hospital's quality improvement team asks physicians to think about this issue every day and order reduced, or "sleep promotion", vital sign checks on patients they believe could safely tolerate it. The investigators goal is to use a predictive analytics tool to reduce the cognitive burden of this task for busy physicians.
The investigators plan to develop a logistic regression model, trained on data from the electronic health record (EHR), to predict, for a given patient on a given night, whether they could safely tolerate the reduction of overnight vital sign checks. The model will use variables, such as the patient's age, the number of days they have been in the hospital, the vital signs from that day, the lab values from that day, and other clinical variables to make its prediction. The outcome is a binary variable, whether the patient will or will not have abnormal vital signs that night. The training data is retrospective therefore it contains the nighttime vitals that were observed, which the investigators will code as a binary variable and use as the outcome variable for the model to train against.
The investigators will incorporate this algorithm into an EHR alert so physicians can observe its output during their work, and use this information, complemented by their own clinical judgment, to decide about ordering reduced vital sign checks for a given patient.
The investigators will study the effect of this EHR alert on several outcomes: in-hospital delirium (measured by nurse assessment), sleep opportunity (a measurement, based on observational EHR data, of patient care related sleep interruptions), and patient satisfaction (measured by nationally-administered post-hospitalization HCAHPS surveys). Balancing measures, to ensure that reduced vital sign checks do not cause patient harm, will be rapid response calls and code blue calls.
Physician teams will be randomized to either see the EHR alert (intervention arm) or not see the EHR alert.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
California
-
San Francisco, California, United States, 94143
- UCSF
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- All physician teams that operate under the UCSF Division of Hospital Medicine
Exclusion Criteria:
- N/A
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: EHR Alert
Physician teams will observe the EHR alert as they perform their clinical duties in the EHR.
|
A pop-up window in the EHR will notify a physician that their patient has been judged by a predictive algorithm to be safe for reduced overnight vital sign checks.
|
|
Placebo Comparator: No Alert
Physician teams will perform their clinical duties in the EHR as usual, with no visible alert.
|
No change to EHR function; no alert visible to providers
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
delirium
Time Frame: average will be measured at study completion (6 months from study start date - Sep 11, 2019)
|
Nursing Delirium Screening Scale (Nu-DESC score) - assessed by the nurse, can range from zero to ten, a score > 2 has good accuracy for delirium
|
average will be measured at study completion (6 months from study start date - Sep 11, 2019)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
sleep opportunity
Time Frame: average will be calculated at study completion (6 months from study start date - Sep 11, 2019)
|
a *novel* measurement based on observational EHR data - for every night in the hospital, the investigators can extract from the EHR all event timestamps that could have interrupted the patient's sleep (measured between 11 pm and 6 am).
These are blood pressure recordings, fingerstick glucose checks, blood draws for labs, and not-as-needed medication administrations.
The maximum time period between such events is considered the patient's sleep opportunity for that night (measured in hours).
A higher sleep-opportunity on a given night is better.
The investigators can calculate an average sleep-opportunity for a hospital encounter and then an average sleep-opportunity for all encounters in a clinical trial arm.
|
average will be calculated at study completion (6 months from study start date - Sep 11, 2019)
|
|
patient satisfaction
Time Frame: average score will be measured at study completion (6 months from study start date - Sep 11, 2019)
|
results from Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) surveys administered to patients after discharge from the hospital (scale is a categorical response: never, sometimes, usually, or always)
|
average score will be measured at study completion (6 months from study start date - Sep 11, 2019)
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
number of code blue events
Time Frame: average number will be calculated at study completion (6 months from study start date - Sep 11, 2019)
|
when a patient has a code blue (respiratory or cardiac arrest) called on them in the hospital, the resuscitation team that responds then writes a note documenting the event; the investigators can count these notes as a proxy for counting code blue events themselves (lower number is better)
|
average number will be calculated at study completion (6 months from study start date - Sep 11, 2019)
|
|
number of rapid response calls
Time Frame: average number will be calculated at study completion (6 months from study start date - Sep 11, 2019)
|
when a patient has a rapid response (significant change in vital signs or alertness) called on them in the hospital, the team that responds writes a note documenting the event and the investigators can count these notes as a proxy for counting rapid response events themselves (lower number is better)
|
average number will be calculated at study completion (6 months from study start date - Sep 11, 2019)
|
Collaborators and Investigators
Investigators
- Study Director: Mark Pletcher, MD, Director of the UCSF Informatics and Research Innovation Program
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- nightvitals
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Delirium
-
Alexandria UniversityCompletedClozapine Poisoning | Hypoactive Delirium | Tricyclic Antidepressant Poisoning | Anticholinergic Delirium | Antipsychotic Toxicity | CNS Depression | Procyclidine Induced DeliriumEgypt
-
Efficacy Care R&D LtdHadassah Medical OrganizationUnknownDelirium | Delirium, Cause Unknown | Delirium of Mixed Origin | Delirium Confusional State | Delirium Drug-InducedIsrael
-
Duke UniversityNot yet recruitingDelirium Confusional State | Hyperactive Delirium | Delirium in the Intensive Care Unit | Agitated DeliriumUnited States
-
Imperial College Healthcare NHS TrustRecruitingCardiac Surgery | Intensive Care Unit Delirium | Post Operative DeliriumUnited Kingdom
-
Sengkang General HospitalRecruitingDelirium and Post-operative Cognitive Dysfunction (POCD) | Delirium, Postoperative | Delirium - PostoperativeSingapore
-
Oslo University HospitalUniversity of Melbourne; Norwegian Academy of MusicCompletedDelirium in Old Age | Delirium of Mixed Origin | Delirium Superimposed on Dementia | Delirium Confusional StateNorway
-
Universitat de LleidaHospital d'IgualadaNot yet recruitingDelirium in Old Age | Delirium Treatment | Delirium Confusional StateSpain
-
Universidad de SantanderUnknownDelirium of Mixed Origin | Hypoactive Delirium | Hyperactive DeliriumColombia
-
Wonkwang University HospitalCompleted
-
Second Affiliated Hospital of Wenzhou Medical UniversityAffiliated Wenling Hospital of Wenzhou Medical UniversityRecruitingInjection | Delirium in Old Age | Post Operative Delirium | Non-cardiac SurgeryChina
Clinical Trials on Nighttime Vital Sign EHR Alert
-
The University of Texas Health Science Center,...Masimo CorporationNot yet recruiting
-
Medical University of South CarolinaSouth Carolina Clinical & Translational Research Institute (SCTR)Active, not recruitingTobacco Use DisorderUnited States
-
Medical University of South CarolinaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...RecruitingMetabolic Dysfunction-associated Steatotic Liver DiseaseUnited States
-
Universitätsklinikum Hamburg-EppendorfRecruitingVital Sign Monitoring | Non-cardiac Surgery | Anesthesiology | Post Operative Complications | RCTGermany
-
Cambridge University Hospitals NHS Foundation TrustUniversity of CambridgeRecruitingPreterm Infant | Low; Birthweight, Extremely (999 Grams or Less) | Infant, NewbornUnited Kingdom
-
NYU Langone HealthMassachusetts General Hospital; University of Pennsylvania; OhioHealthCompleted
-
Bispebjerg HospitalActive, not recruitingRemote Monitoring | Vital Signs Monitoring | Hospital at Home | Continuous MonitoringDenmark
-
University Health Network, TorontoCompletedBlood Pressure, Heart Rate, Breathing Rate and Oxygen LevelCanada
-
Centre for Infectious Disease Research in ZambiaWellcome Trust; Neopenda, PBCCompleted